Michael Wall, MD


Director, Neuro-Ophthalmology Clinic, Neurology
Professor of Neurology
Professor of Ophthalmology and Visual Sciences

Contact Information

Primary Office: 2149 RCP
Iowa City, IA 52242



MD, Medicine, Tulane University

Residency, Neurology, Washington University in St. Louis
Fellowship, Neuro-ophthalmology, Harvard University

Research Summary

Dr. Wall's research has two arms. The first is to develop strategies of visual field testing that detect visual field defects at an earlier stage and visual field change at an earlier time. To achieve these goals, we have been studying mechanisms of perimetric variability. We have been funded for this with a VA Merit review for the past 12 years. During this time we have shown that a substantial portion of the variability of perimetry is due to the stimulus size chosen. In the process, we have developed a method of visual field testing, motion perimetry, that takes advantage of these findings to lower retest variability. We are in the fourth year of a 5 year study that follows glaucoma patients with four visual field tests to determine if larger stimuli result in earlier detection of visual field change. The second arm of the research is to study idiopathic intracranial hypertension (pseudotumor cerebri) a disease of overweight women in the childbearing years that causes headache and blindness. Our goal is to find the cause of the disease and to develop evidence-based treatment strategies. Currently all treatment decisions are based on data that is retrospective and uncontrolled. Our clinical trial has now been funded by the NIH for $16 million over 5 years. The specific aims of 1) determining if diet and acetazolamide is superior to diet alone; 2) with the help of Edwin Stone's laboratory, using a genome wide association study better understand the mechanism of idiopathic intracranial hypertension.

All Publications

Wall M, Falardeau J, Fletcher W, Granadier R, Lam B, Longmuir R, Patel A, Bruce B, He H, McDermott M.  Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.  Neurology.  2015 September 1. 85(9):799-805.

Digre K, Bruce B, McDermott M, Galetta K, Balcer L, Wall M.  Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results..  Neurology.  2015 June 16. 84(24):2449-56.

Chen J, Thurtell M, Longmuir R, Garvin M, Wang J, Wall M, Kardon R.  Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension..  Investigative ophthalmology & visual science.  2015 June 1. 56(6):3850-9.

Fischer W, Wall M, McDermott M, Kupersmith M, Feldon S.  Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results..  Investigative ophthalmology & visual science.  2015 May 1. 56(5):3292-303.

Rizzo J, Lam K, Wall M, Wilson M, Keltner J.  Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension..  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.  2015 March 1. 35(1):22-5.

Wall M, McDermott M, Kieburtz K, Kupersmith M.  Treating idiopathic intracranial hypertension--reply..  JAMA neurology.  2014 October 1. 71(10):1327-8.

Wall M, McDermott M, Kupersmith M.  Idiopathic intracranial hypertension--reply..  JAMA.  2014 September 10. 312(10):1060.

Wall M, Corbett J.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children..  Neurology.  2014 July 8. 83(2):198-9.

Johnson C, Sherman K, Doyle C, Wall M.  A Comparison of False-negative Responses for Full Threshold and SITA Standard Perimetry in Glaucoma Patients and Normal Observers.  J Glaucoma.  2014. 23(5):288-92.

Keltner J, Johnson C, Cello K, Wall M.  Baseline Visual Field Findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).  Invest Ophthalmol Vis Sci.  2014. 55(5):3200-07.

Thurtell M, Kirby P, Wall M.  Bilateral jugular paragangliomas: a rare cause of raised intracranial pressure.  Neurology.  2014. 82(8):732-3.

Nordic Idiopathic Intracranial Hypertension Study Group Writing Committee , Wall M, McDermott M, Kieburtz K, Corbett J, Feldon S, Friedman D, Katz D, Keltner J, Schron E, Kupermsith M.  Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.  JAMA.  2014. 311(16):1641-51.

Chen J, Wall M.  Epidemiology and risk factors for idiopathic intracranial hypertension.  Int Ophthalmol Clin.  2014. 54(1):1-11.

Wall M, Kupersmith M, Kieburtz K, Corbett J, Feldon S, Friedman D, Katz D, Keltner J, Schron E, McDermott M, Nordic Idiopatic Intracranial Hypertension Study Group .  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.  JAMA Neurology.  2014. 71(6):693-701.

Thurtell M, Wall M.  Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management.  Current treatment options in neurology.  2013. 15(1):1-12.

Wall M.  Idiopathic intracranial hypertension and the idiopathic intracranial hypertension treatment trial.  J Neuroophthalmol.  2013. 33(1):1-3.

Warren D, Thurtell M, Carroll J, Wall M.  Perimetric evaluation of saccadic latency, saccadic accuracy, and visual threshold for peripheral visual stimuli in young compared with older adults.  Invest Ophthalmol Vis Sci.  2013. 54(8):5778-87.

Kummet C, Zamba K, Doyle C, Johnson C, Wall M.  Refinement of pointwise linear regression criteria for determining glaucoma progression.  Invest Ophthalmol Vis Sci.  2013. 54(9):6234-41.

Wall M, Doyle C, Eden T, Zamba K, Johnson C.  Size Threshold Perimetry Performs as well as Conventional Automated Perimetry with Stimulus Sizes III, V and VI for Glaucomatous Loss.  Invest Ophthalmol Vis Sci.  2013. 54(6):3975-83.

Wall M, Doyle C, Zamba K, Artes P, Johnson C.  The Repeatability of Mean Defect with Size III and Size V Standard Automated Perimetry.  Invest Ophthalmol Vis Sci.  2013. 54(2):1345-51.

Lee A, Wall M.  Papilledema: Are We Any Nearer to a Consensus on Pathogenesis and Treatment? .  Current Neurology and Neuroscience Reports.  2012. 12(3):334-9.

Vislisel J, Doyle C, Johnson C, Wall M.  Variability of rarebit and standard perimetry sizes I and III in normals.  Optom Vis Sci.  2011 May. 88(5):635-9.

Wall M, Corbett J.  Cup-to-Disc Ratio in Patients With Idiopathic Intracranial Hypertension Is Smaller Than in Normal Subjects? .  J Neuroophthalmol.  2011. 31(1):95-6.

Wittes J, Gorin M, Mayne S, McCarthy C, Sternberf Jr P, Wall M.  Letter From the DSMC Regarding a Clinical Trial of Lutein in Patients With Retinitis Pigmentosa.  Arch Ophthalmol.  2011. 129(5):675.

Kardon R, Scott C, Lee A, Frisen L, Wall M.  Optical coherence tomography for optic disc edema--reply.  Arch Ophthalmol.  2011. 129(9):1246-7.

Johnson C, Wall M.  The visual field.  Saunders, Elsevier.  2011. 

Johnson C, Wall M, Thompson H.  A history of perimetry and visual field testing.  Optom Vis Sci.  2011 January. 88(1):E8-15.

Sample P, Dannheim F, Artes P, Dietzsch J, Henson D, Johnson C, Ng M, Schiefer U, Wall M.  Imaging and Perimetry Society standards and guidelines.  Optom Vis Sci.  2011 January. 88(1):4-7.

Tang L, Kwon Y, Alward W, Greenlee E, Lee K, Garvin M, Abramoff M.  3D reconstruction of the optic nerve head using stereo fundus images for computer-aided diagnosis of glaucoma.  Proceedings of the SPIE -The International Society for Optical Engineering (Progress in Biomedical Optics and Imaging Medical Imaging 2009: Biomedical Applications in Molecular, Structural, and Functional Imaging).  2010. 7624:76243D.

Scott C, Kardon R, Lee A, Frisen L, Wall M.  Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale.  Arch Ophthalmol.  2010. 128(6):705-11.

Wall M.  Idiopathic intracranial hypertension.  Neurol Clin.  2010. 28(3):593-617.

Wall M, Woodward K, Doyle C, Zamba G.  The Effective Dynamic Ranges of Standard Automated Perimetry Sizes III and V and Motion and Matrix Perimetry.  Arch Ophthalmol.  2010. 128(5):570-6.

Hood D, Anderson S, Wall M, Raza A, Kardon R.  A Test of a Linear Model of Glaucomatous Structure-Function Loss Reveals Sources of Variability in Retinal Nerve Fiber and Visual Field Measurements.  Invest Ophthalmol Vis Sci.  2009. 50(9):4254-66.

Wall M, Purvin V.  Idiopathic intracranial hypertension in men and the relationship to sleep apnea.  Neurology.  2009. 72(4):300-1.

Anderson A, Shuey N, Wall M.  Rapid confrontation screening for peripheral visual field defects and extinction.  Clin Experiment Optom.  2009. 92(1):45-8.

Wall M, Woodward K, Doyle C, Artes P.  Repeatability of Automated Perimetry: A Comparison between Standard Automated Perimetry with Stimulus Size III and V, Matrix, and Motion Perimetry.  Invest Ophthalmol Vis Sci.  2009. 50(2):974-9.

Kupersmith M, Miller N, Balcer L, Gordon L, Wall M, Keltner J, Friedman D, Feldon S, McDermott M, Kieburtz K.  The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC).  J Neuroophthalmol.  2009. 29(3):259-61.

Wall M, Johnson C, Kardon R, Crabb D.  Use of a Continuous Probability Scale to Display Visual Field Damage.  Arch Ophthalmol.  2009. 127(6):749-56.

Wall M, Doyle C, Britto C, Woodward K, Johnson C.  A Comparison of Catch Trial Methods Used in Standard Automated Perimetry in Glaucoma Patients.  J Glaucoma.  2008. 17(8):626-30.

Huang C, Carolan J, Redline D, Taravati P, Woodward K, Johnson C, Wall M, Keltner J.  Humphrey Matrix Perimetry in Optic Nerve and Chiasmal Disorders: Comparison with Humphrey SITA Standard 24-2.  Invest Ophthalmol Vis Sci.  2008. 49(3):917-23.

Wall  M.  Idiopathic intracranial hypertension (pseudotumor cerebri).  Current Neurology and Neuroscience Reports.  2008. 8(2):87-93.

Wall M.  Idiopathic intracranial hypertension (pseudotumor cerebri).  Insight.  2008. 33(2):18-25; quiz 6-7.

Dave S, Longmuir R, Shah V, Wall M, Lee A.  Intracranial hypertension in systemic lupus erythematosus.  Semin Ophthalmol.  2008. 23(2):127-33.

Shah V, Kardon R, Lee A, Corbett J, Wall M.  Long-term follow-up of idiopathic intracranial hypertension: The Iowa experience.  Neurology.  2008. 70(8):634-40.

Brodsky M, Nazarian S, Orengo-Nania S, Hutton G, Buckley E, Massey E, Bhatti M, Greer M, Goodwin J, Wall M, Savino P, Leist T, Miller N, Irani D, Trobe J, Cornblath W, Kaufman D, Eggenberger E, Kupersmith M, Shults W, McAllister L, Hamilton S, Beck R, Dontchev M, Gal R, Kollman C, Keltner J, Smith C.  Multiple sclerosis risk after optic neuritis - Final optic neuritis treatment trial follow-up. .  Arch Ophthalmol.  2008. 65(6):727-32.

Koczman J, Rouleau J, Gaunt M, Kardon R, Wall M, Lee A.  Neuro-ophthalmic Sarcoidosis: The University of Iowa Experience.  Semin Ophthalmol.  2008. 23(3):157-68.

Taravati P, Woodward K, Keltner J, Johnson C, Redline D, Carolan J, Huang C, Wall M.  Sensitivity and Specificity of the Humphrey Matrix to Detect Homonymous Hemianopsias.  Invest Ophthalmol Vis Sci.  2008. 49(3):924-8.

Wall M, Brito C, Woodward K, Doyle C, Kardon R, Johnson C.  Total Deviation Probability Plots for Stimulus Size V Perimetry: A Comparison With Size III Stimuli.  Arch Ophthalmol.  2008. 126(4):473-9.

Wall M, Musser C, Carney B, Longmuir R, Randhawa S, Shah V.  Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.  Ophthalmology.  2008. 115(6):1079-82 e5.

Shah V, Fung S, Shahbaz R, Taktakishvili O, Wall M, Lee A.  Idiopathic intracranial hypertension.  Ophthalmology.  2007. 114(3):617-8.

Daniels A, Liu G, Volpe N, Galetta S, Moster M, Newman N, Biousse V, Lee A, Wall M, Kardon R, Acierno M, Corbett J, Maguire M, Balcer L.  Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri).  Am J Ophthalmol.  2007. 143(4):635-41.

Ashida H, Lingau A, Wall M, Smith A.  Speed tuning in human visual cortex: An fMRI adaptation study.  Perception.  2007. 36:110.

Hood D, Anderson S, Wall M, Kardon R.  Structure versus Function in Glaucoma: An Application of a Linear Model.  Invest Ophthalmol Vis Sci.  2007. 48(8):3662-8.

Ayala-Lugo R, Pawar H, Reed D, Lichter P, Moroi S, Page M, Eadie J, Azocar V, Maul E, Ntim-Amponsah C, Bromley W, Obeng-Nyarkoh E, Johnson A, Kijek T, Downs C, Johnson J, Perez-Grossmann R, Guevara-Fujita M, Fujita R, Wallace M, Richards J.  Variation in optineurin (OPTN) allele frequencies between and within populations.  Mol Vis.  2007. 13(18-19):151-63.

Wendel L, Lee A, Boldt H, Kardon R, Wall M.  Subretinal neovascular membrane in idiopathic intracranial hypertension.  Am J Ophthalmol.  2006 March. 141(3):573-4.

Parikh M, Miller N, Lee A, Savino P, Vacarezza M, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M.  Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.  Ophthalmology.  2006. 113(10):1842-5.

Dinn R, Wall M.  Tadalafil associated with typical migraine aura without headache.  Cephalalgia.  2006. 26(11):1344-6.

Anderson A, Johnson C, Fingeret M, Keltner J, Spry P, Wall M, Werner J.  Characteristics of the normative database for the Humphrey matrix perimeter.  Invest Ophthalmol Vis Sci.  2005 April. 46(4):1540-8.

Balcer L, Daniels A, Liu G, Volpe N, Galetta S, Moster M, Newman N, Biousse V, Lee A, Wall M, Kardon R, Acierno M, Corbett J, Maguire M.  Obesity profile, risk factors, and quality of life in idiopathic intracranial hypertension (IIH).  Neurology.  2005. 64(6 (Suppl 1)):A37-A8.

Lee A, Chau F, Golnik K, Kardon R, Wall M.  The diagnostic yield of the evaluation for isolated unexplained optic atrophy.  Ophthalmology.  2005. 112(5):757-9.

Lee A, Pless M, Falardeau J, Capozzoli T, Wall M, Kardon R.  The use of acetazolamide in idiopathic intracranial hypertension during pregnancy.  Am J Ophthalmol.  2005. 139(5):855-9.

Beck R, Gal R, Bhatti M, Brodsky M, Buckley E, Chrousos G, Corbett J, Eggenberger E, Goodwin J, Katz B, Kaufmann D, Keltner J, Kupersmith M, Miller N, Moke P, Nazarian S, Orengo-Nania S, Savino P, Shuts W, Smith C, Trobe J, Wall M, Xing D.  [Erratum] Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. (vol 137, pg 77, 2004).  Am J Ophthalmol.  2004. 138(2):322.

Eggenberger E, Beck R, Gal R, Xing D, Trobe J, Arrington J, Murtagh F, Bhatti M, Brodsky M, Buckley E, Chrousos G, Corbett J, Goodwin J, Katz B, Kaufman D, Keltner J, Kupersmith M, Miller N, Moke P, Orengo-Nania S, Nazarian S, Savino P, Shults W, Smith C, Wall M.  Long-term brain magnetic resonance imaging changes after optic neuritis in patients without clinically definite multiple sclerosis - Optic Neuritis Study Group.  Arch Neurol.  2004. 61(10):1538-41.

Lee A, Eggenberger E, Galetta S, Kerrison J, Miller N, Kirby P, Wall M, Hitchon P, Kardon R.  Neuro-ophthalmic manifestations of hemangiopericytoma.  Semin Ophthalmol.  2004. 19(3-4):95-100.

Beck R, Smith C, Gal R, Xing D, Bhatti M, Brodsky M, Buckley E, Chrousos G, Corbett J, Eggenberger E, Goodwin J, Katz B, Kaufman D, Keltner J, Kupersmith M, Miller N, Moke P, Nazarian S, Orengo-Nania S, Savino P, Shults W, Trobe J, Wall M,  .  Neurologic impairment 10 years after optic neuritis.  Arch Neurol.  2004. 61(9):1386-9.

Gal R, Beck R, Smith C, Xing D, Bhatti M, Brodsky M, Buckley E, Chrousos G, Corbett J, Eggenberger E, Goodwin J, Katz B, Kaufman D, Keltner J, Kupersmith M, Miller N, Moke P, Nazarian S, Orengo-Nania S, Savino P, Schults W, Trobe J, Wall M.  Neurologic impairment 10 years after optic neuritis - Optic Neuritis Study Group.  Arch Neurol.  2004. 61(9):1386-9.

Lee A, Anderson R, Kardon R, Wall M.  Presumed 'sulfa allergy' in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality?.  Am J Ophthalmol.  2004. 138(1):114-8.

Wall M, Woodward K, Brito C.  The effect of attention on conventional automated perimetry and luminance size threshold perimetry.  Invest Ophthalmol Vis Sci.  2004. 45(1):342-50.

Wall M, Chauhan B, Frisen L, House P, Brito C.  Visual Field of High-Pass Resolution Perimetry in Normal Subjects.  J Glaucoma.  2004. 13(1):15-21.

Beck R, Gal R, Bhatti M, Brodsky M, Buckley E, Chrousos G, Corbett J, Eggenberger E, Goodwin J, Katz B, Kaufman D, Keltner J, Kupersmith M, Miller N, Moke P, Nazarian S, Orengo-Nania S, Savino P, Shults W, Smith C, Trobe J, Wall M, Xing D,  .  Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial.[erratum appears in Am J Ophthalmol. 2004 Apr;137(4):following 793].  Am J Ophthalmol.  2004. 137(1):77-83.

Wall M.  What's new in perimetry.  Journal of Neuro Ophthalmology.  2004. 24(1):46-55.

 , Beck R, Trobe J, Moke P, Gal R, Xing D, Bhatti M, Brodsky M, Buckley E, Chrousos G, Corbett J, Eggenberger E, Goodwin J, Katz B, Kaufman D, Keltner J, Kupersmith M, Miller N, Nazarian S, Orengo-Nania S, Savino P, Schults W, Smith C, Wall M.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.  Arch Ophthalmol.  2003. 121(7):944-9.

Wall M.  Visual Fields.  Academic Press.  2003. 

O'Connor P, Fleming P, Gray T, Jacobs L, Miller C, Munschauer F, Kinkel R, Bolibrush D, Cohen J, Freedman M, Webb U, Rabinowicz H, Metz L, Davis A, Patry D, Hashimoto S, Morrison W, Oger J, Panitch H, Costello K, Bever C, Stuart W, Court D, Stuart D, Tornatore C, Simon J, Wall M, et al .  Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial.  Mult Scler.  2002. 8(4):330-8.

Costello F, Kardon R, Wall M, Kirby P, Ryken T, Lee A.  Papilledema as the presenting manifestation of spinal schwannoma.  J Neuroophthalmol.  2002. 22(3):199-203.

Eggenberger E, Golnik K, Lee A, Santos R, Suntay A, Satana B, Vaphlades M, Stevens C, Kaufman D, Wall M, Kardon R.  Prognosis of ischemic internuclear ophthalmoplegia.  Ophthalmology.  2002. 109(9):1676-8.

Wall M, Neahring R, Woodward K.  Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: A comparison with conventional automated perimetry.  Invest Ophthalmol Vis Sci.  2002. 43(4):1277-1283.

Lee A, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S.  Sleep apnea and intracranial hypertension in men.  Ophthalmology.  2002. 109(3):482-5.

Wall M, Kutzko K, Chauhan B.  The relationship of visual threshold and reaction time to visual field eccentricity with conventional automated perimetry.  Vision Res.  2002. 42(6):781-7.

Kardon R, Givre S, Wall M, Hood D.  Comparison of threshold and multifocal-visual evoked potential perimetry in recovered optic neuritis.  Kugler.  2001. 

Wall M, Woodward K.  Frequency doubling perimetry fails to detect some patients with hemianopias.  Kugler.  2001. 

O'Connor P, Fleming P, Gray T, Jacobs L, Miller C, Munschauer F, Kinkel R, Bolibrush D, Cohen J, Freedman M, Webb U, Rabinowicz H, Metz L, Patry D, Yeung M, Peters S, Hashimoto S, Morrison W, Oger J, Panitch H, Costello K, Bever C, Stuart W, Court D, Stuart D, Beck R, Wall M, et al .  Interferon beta-1 a for optic neuritis patients at high risk for multiple sclerosis.  Am J Ophthalmol.  2001. 132(4):463-71.

 .  Perimetry Update 2000/2001: Proceedings of the XIVth International Perimetric Society Meeting, Halifax, Canada, September 6-9, 2000.  Kugler;  2001.

Wall M, Punke S, Stickney T, Brito C, Withrow K, Kardon R.  SITA standard in optic neuropathies and hemianopias: A comparison with full threshold testing. .  Invest Ophthalmol Vis Sci.  2001. 42(2):528-37.

Kutzko K, Brito C, Wall M.  Effect of instructions on conventional automated perimetry.  Invest Ophthalmol Vis Sci.  2000. 41(7):2006-2013.

Alward W.  Frequency doubling technology perimetry for the detection of glaucomatous visual field loss [editorial].  Am J Ophthalmol.  2000. 129(3):376-8.

Wall M.  Idiopathic intracranial hypertension: Mechanisms of visual loss and disease management.  Semin Neurol.  2000. 20(1):89-95.

Givre S, Wall M, Kardon R.  Visual loss and recovery in a patient with Friedreich ataxia.  J Neuroophthalmol.  2000. 20(4):229-33.

Donahue S, Wall M, Kutzko K, Kardon R.  Automated perimetry in amblyopia: a generalized depression.  Am J Ophthalmol.  1999. 127(3):312-21.

Wall M.  Chapter 303: Multiple sclerosis.  W. B. Saudners.  1999. 

Adams C, Bullimore M, Wall M, Fingeret M, Johnson C.  Normal aging effects for frequency doubling technology perimetry.  Optom Vis Sci.  1999. 76(8):582-587.

Wall M, Jennisch C.  Random dot motion stimuli are more sensitive than light stimuli for detection of visual field loss in ocular hypertension patients.  Optom Vis Sci.  1999. 76(8):550-557.

Jacobson D, Berg R, Wall M, Digre K, Corbett J, Ellefson R.  Serum vitamin A concentration is elevated in idiopathic intracranial hypertension.  Neurology.  1999. 53(5):1114-8.

Johnson C, Wall M, Fingeret M, Lalle P.  A primer for frequency doubling technology.  WelchAllyn;  1998.

Wall M, White W.  Asymmetric papilledema in idiopathic intracranial hypertension: prospective intraocular comparison of sensory visual function.  Invest Ophthalmol Vis Sci.  1998. 39(1):134-142.

Riedel P, Wall M, Grey A, Cannon T, Folberg R.  Autoimmune optic neuropathy.  Arch Ophthalmol.  1998. 116(8):1121-4.

Kupersmith M, Gamell L, Turbin R, Peck V, Spiegel P, Wall M.  Effects of weight loss on the couse of idiopathic intracranial hypertension in women.  Neurology.  1998. 50:1094-1098.

Wall M, Johnson C, Kutzko K, Nguyen R, Brito C, Keltner J.  Long- and short-term variability of automated perimetry results in patients with optic neuritis and healthy subjects.  Arch Ophthalmol.  1998. 116(1):53-61.

Donahue S, Wall M, Kutzko K.  Motion perimetry in anisometropic amblyopia: elevated thresholds throughout the visual field.  J AAPOS.  1998. 2(2):94-101.

Wall M.  Optic Radiations and Occipital Cortex.  Williams & Wilkins.  1998. 

White W, Corbett J, Wall M.  Raised intracranial pressure.  Mosby.  1998. 

Corbett J, Wall M.  The Optic Nerve Head: Elevated Discs.  Mosby.  1998. 

Patel A, Wall M, Withrow K, Kutzko K.  A comparison of mtion detection and direction discrimination thresholds in patients with optic nerve damage from idiopathic intracranial hypertension (sbatrct #340).  Invest Ophthalmol Vis Sci.  1997. 38(4):S70.

Wall M, Donzis P.  Luminance contrast and colour contrast related errors in pseudoisochromatic plate identification.  Eye.  1997. 11(5):713-716.

Wall M, Hennisch C, Munden P.  Motion Perimetry identifies nerve fiber bundlelike defects in ocular hypertension.  Arch Ophthalmol.  1997. 115(1):26-33.

Wall M.  Postgeniculate afferent visual system and visual higher cortical function, 1995-1996.  J Neuroophthalmol.  1997. 17(3):209-217.

 , Brodsky M, Jay W, Johnson P, Lamey D, Cain S, Wheeler B, Lam B, Nazarian S, Nichols J, Buckholts A, Ford R, Orengonania S, McCray J, Rolak L, Slight B, Chung S, Gross R, Howard A, Lai E, Frady P, Katz B, Foltos C, Ambrosio T, Cruz T, Hawker N, Thompson H, Wall M.  The 5-year risk of MS after optic neuritis: experience of the Optic Neuritis Treatment Trial..  Neurology.  1997. 49(5):1404-1413.

Wall M, Kutzko K, Chauhan B.  Variability in patients with glaucomatous visual field damage is reduced using size V stimuli.  Invest Ophthalmol Vis Sci.  1997. 38(2):426-435.

Vanden Bosch M, Wall M.  Visual acuity scored by the letter-by-letter or probit methods has lower retest variability than the line assignment method.  Eye.  1997. 11(part 3):411-7.

 , Beck R, Trobe J, Moke P, Brodsky M, Buckley E, Chrousos G, Goodwin J, Guy J, Katz B, Kaufman D, Keltner J, Kupersmith M, Miller N, Orengo-Nania S, Savino P, Shults W, Smith C, Thompson H, Wall M, et al .  Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial.  Arch Ophthalmol.  1997. 115(12):1545-52.

Wall M.  Brainstem syndromes.  Butterworths.  1996. 

Lam B, Thompson H, Walls R.  Effect of Light on the Prevalence of Simple Aniscoria.  Ophthalmology.  1996. 103(5):790-793.

Corbett J, Wall M.  Idiopathic intracranial hypertension.  Williams and Wilkins.  1996. 

Wall M.  Postgeniculate afferent visual system and visual higher cortical function, 1994.  J Neuroophthalmol.  1996. 16(1):23-32.

Boghen D, Katz B, Wall M.  She could not look to either side.  Surv Ophthalmol.  1996. 41(2):165-170.

Wall M, Maw R, Stanek K, Chauhan B.  The psychometric function and reaction times of automated perimetry in normal and abnormal areas of the visual field in patients with glaucoma.  Invest Ophthalmol Vis Sci.  1996. 37(5):878-885.

Wall M, Dollar J, Sadun A, Kardon R.  Idiopathic intracranial hypertension: lack of histologic evidence for cerebral edema.  Arch Neurol.  1995. 52(2):141-145.

Wall M, Breen L, Winterkorn J.  Optic disk edema with cotton-wool spots [comments].  Surv Ophthalmol.  1995. 39(6):502-508.

Gu X, Tsai J, Wurdeman A, Wall M, Foote T, Sadun A.  Pattern of axonal loss in long standing papilledema due to idiopathic intracranial hypertension.  Curr Eye Res.  1995. 14(3):173-180.

Wall M, Ketoff K.  Random Dot Motion Perimetry in Glaucoma Patients and Normal Subjects.  Am J Ophthalmol.  1995. 120(5):587-96.

Wall M.  The retrogeniculate sensory visual system and higher cortical function, 1993.  J Neuroophthalmol.  1995. 15(1):48-55.

Moster M, Slavin M, Wall M.  Unilateral disk edema in a young woman.  Surv Ophthalmol.  1995. 39(5):409-416.

Wall M, Montgomery E.  Using motion perimetry to detect visual field defects in patients with idiopathic intracranial hypertension: a comparison with conventional automated perimetry.  Neurology.  1995. 45(6):1169-1175.

Donahue S, Wall M, Weingeist T.  Interferon treatment of SRNV [letter].  Ophthalmology.  1994. 101(4):624-625.

Wall M.  Multiple Sclerosis.  W B Saunders.  1994. 

Katz B, Wall M.  The Optic Neuropathies.  Mosby.  1994. 

Wall M, Corbett J.  Arteritis.  Raven Press.  1993. 

Wall M.  Nerve sheath decompression in patients with functioning shunts [letter].  Ophthalmology.  1992. 99(4):480.

Katz B, Newman S, Wall M.  Disc edema, transient obscurations of vision, and a temporal fossa mass.  Surv Ophthalmol.  1991. 36:133-139.

Wall M, Conway M, House P, Allely R.  Evaluation of sensitivity and specificity of spatial resolution and Humphrey automated perimetry in pseudotumor cerebri patients and normal subjects..  Invest Ophthalmol Vis Sci.  1991. 32(13):3306-3312.

Wall M.  High-pass resolution perimetry in optic neuritis.  Invest Ophthalmol Vis Sci.  1991. 32(9):2525-2529.

Wall M.  Idiopathic intracranial hypertension.  Neurologic Clinics of North America.  1991. 9(1):73-95.

Wall M, George D.  Idiopathic intracranial hypertension: a prospective study of 50 patients.  Brain.  1991. 114(pt 1A):155-180.

Ridgway D, Wolff L, Wall M, Borzy M, Kirkpatrick C.  Indomethacin-sensitive monocyte killing defect in a child with disseminated atypical mycobacterial disease.  J Clin Immunol.  1991. 11(6):357-62.

Wall M, Newman S, Slavin M, Sedwick L.  Optic atrophy [clinical conference].  Surv Ophthalmol.  1991. 36(1):51-58.

Wall M, Newman S.  Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy [letter, comment].  Am J Ophthalmol.  1991. 112(6):741-742.

Giuseffi V, Wall M, Siegel P, Rojas P.  Sympsoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case control study.  Neurology.  1991. 41(2):239-244.

Wall M.  The Morphology of visual field damage in idiopathic intracranial hypertension: an anatomic region analysis.  Kugler.  1991. 

Wall M.  The Visual Field.  Mosby-Year Book.  1991. 

Wall M, Lefante J, Conway M.  Variability of high-pass resolution perimetry in normals and patients with idiopathic intracranial hypertension.  Invest Ophthalmol Vis Sci.  1991. 32(12):3091-3095.

Tweten S, Wall M, Schwartz B.  A comparison of three clinical methods of spatial contrast-sensitivity testing in normal subjects.  Graefes Arch Clin Exp Ophthalmol.  1990. 228:24-27.

Wall M.  Loss of P retinal ganglion cell function in resolved optic neuritis.  Neurology.  1990. 40(4):649-653.

Wall M, Collins C, May D.  Low-intensity grids improve sensitivity of Amsler Grid Testing in diabetic patients without background retinopathy.  Ann Ophthalmol.  1990. 22:96-100.

Wall M.  Sensory visual testing in idiopathic intracranial hypertension: measures sensitive to change.  Neurology.  1990. 40(12):1859-1864.

Wall M.  The headache profile of idiopathic intracranial hypertension.  Cephalagia.  1990. 10:331-335.

Durcan F, Corbett J, Wall M.  The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana.  Arch Neurol.  1988. 45(8):875-877.

Carlow T, Corbett J, Goodwin J, Kupersmith M, Meckler R, Sharpe J, Smith C, Wall M.  The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana.  Arch Neurol.  1987. 44(2):128-129.

Date Last Modified: 08/04/2015 - 09:28:35